Home Cart 0 Sign in  
X

[ CAS No. 1194-02-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 1194-02-1
Chemical Structure| 1194-02-1
Chemical Structure| 1194-02-1
Structure of 1194-02-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1194-02-1 ]

Related Doc. of [ 1194-02-1 ]

Alternatived Products of [ 1194-02-1 ]

Product Details of [ 1194-02-1 ]

CAS No. :1194-02-1 MDL No. :MFCD00001812
Formula : C7H4FN Boiling Point : -
Linear Structure Formula :- InChI Key :AEKVBBNGWBBYLL-UHFFFAOYSA-N
M.W : 121.11 Pubchem ID :14517
Synonyms :

Calculated chemistry of [ 1194-02-1 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 31.12
TPSA : 23.79 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.66 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 1.94
Log Po/w (WLOGP) : 2.12
Log Po/w (MLOGP) : 1.88
Log Po/w (SILICOS-IT) : 2.24
Consensus Log Po/w : 1.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.31
Solubility : 0.598 mg/ml ; 0.00494 mol/l
Class : Soluble
Log S (Ali) : -2.06
Solubility : 1.05 mg/ml ; 0.00863 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.71
Solubility : 0.234 mg/ml ; 0.00193 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.4

Safety of [ 1194-02-1 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P210-P240-P241-P261-P264-P270-P271-P280-P301+P312+P330-P302+P352+P312+P362+P364-P304+P340+P312-P305+P351+P338+P337+P313-P501 UN#:1325
Hazard Statements:H228-H302+H312+H332-H315-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 1194-02-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1194-02-1 ]
  • Downstream synthetic route of [ 1194-02-1 ]

[ 1194-02-1 ] Synthesis Path-Upstream   1~56

  • 1
  • [ 1194-02-1 ]
  • [ 16209-00-0 ]
Reference: [1] Patent: US2016/185785, 2016, A1,
[2] Patent: US2016/185786, 2016, A1,
  • 2
  • [ 1194-02-1 ]
  • [ 22090-24-0 ]
Reference: [1] Molecular Crystals and Liquid Crystals (1969-1991), 1985, vol. 124, p. 269 - 276
  • 3
  • [ 288-32-4 ]
  • [ 1194-02-1 ]
  • [ 25372-03-6 ]
YieldReaction ConditionsOperation in experiment
93% With sodium hydride In N,N-dimethyl-formamide at 20 - 100℃; 1500 ml of dry dimethylformamide (DMF) are placed in a 1000 ml four-necked flask while passing nitrogen over it and 72.67 g (0.6 mol) of 4-fluorocyanobenzene and 61.2 g (0.9 mol) of imidazole and finally 21.6 g (0.9 mol) of sodium hydride are added. The reaction mixture is heated to 100° C., stirred at this temperature for 4 hours and subsequently overnight at room temperature. The reaction mixture is then poured into water and the resulting mixture is extracted a number of times with dichloromethane. The organic phase is dried, evaporated on a rotary evaporator and finally dried further at 60° C. under reduced pressure. The yield is 94 g (93percent of theory).1H-NMR (400 MHz, CDCl3): δ=7.27 (s, 1H); 7.35 (s, 1H); 7.54 (d, J=8.8 Hz, 2H); 7.81 (d, J=8.8 Hz, 2H); 7.95 (s, 1H).
Reference: [1] Synthetic Communications, 2008, vol. 38, # 4, p. 626 - 636
[2] Patent: WO2006/56418, 2006, A2, . Location in patent: Page/Page column 57
[3] Patent: US2009/18330, 2009, A1, . Location in patent: Page/Page column 14
[4] Advanced Synthesis and Catalysis, 2007, vol. 349, # 11-12, p. 1938 - 1942
[5] Monatshefte fur Chemie, 2004, vol. 135, # 4, p. 419 - 423
[6] Journal of Organic Chemistry, 2011, vol. 76, # 4, p. 1151 - 1154
[7] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 18, p. 3879 - 3887
[8] Tetrahedron Letters, 2009, vol. 50, # 12, p. 1286 - 1289
[9] Journal of Materials Chemistry A, 2017, vol. 5, # 2, p. 535 - 543
  • 4
  • [ 1194-02-1 ]
  • [ 18156-74-6 ]
  • [ 25372-03-6 ]
YieldReaction ConditionsOperation in experiment
77%
Stage #1: With cesium fluoride In N,N-dimethyl-formamide for 0.166667 h; Inert atmosphere
Stage #2: at 60℃; for 20 h;
Under a nitrogen atmosphere 362 mg (2.38 mmol) of CsF, previously activated with NaOH, were suspended in 5 ml of DMF and stirred for 30 min. Then, 1.00 g (8.26 mmol) of 4-fluorobenzonitrile was added. After 10 min 1.20 ml (8.18 mmol) N-trimethylsilylimidazole were added and the mixture was stirred at 60° C. for 20 hr. For workup, most of the solvent was removed under vacuum (oil pump), and then 5 ml of water and 5 ml of CH2Cl2 were added to the reaction mixture. The organic phase was separated, the aqueous phase was extracted with CH2Cl2, the organic phases were combined, washed several times with water and dried over MgSO4. The solvent was removed under vacuum, and the resulting solid was rinsed twice with pentane.Yield: 1.07 g (6.31 mmol, 77percent), appearance: colorless solid. 1H NMR (CDCl3, 25° C., 400.13 MHz): δ=7.25 (s, 1H, ImH), 7.33 (s, 1H, ImH), 7.51-7.53 (m, 2H, PhH), 7.79-7.81 (m, 2H, PhH), 7.94 (s, 1H, ImH). 13C NMR (CDCl3, 25° C., 100.61 MHz): δ=111.3 (C-1), 117.7 (C-9), 117.9 (-CN), 121.5 (C-3, C-5), 131.6 (C-8), 134.2 (C-2, C-6), 135.4 (C-7) 140.6 (C-4).
Reference: [1] Patent: US2012/142937, 2012, A1, . Location in patent: Page/Page column 5
  • 5
  • [ 1194-02-1 ]
  • [ 5587-42-8 ]
  • [ 25372-03-6 ]
YieldReaction ConditionsOperation in experiment
78% at 80℃; for 12 h; A mixture 4-fluorobenzonitrile (3 g, 25 MMOL) and imidazolyl sodium (2. 48 g, 27.5 MMOL) in DMF (50 mL) was stirred at 80 C under Ar for 12 h. Progress of reaction was monitored by TLC. The reaction mixture was concentrated in vacuo and the residue was diluted with 50 mL water and stirred. The aqueous mixture was extracted with EtOAc (2 x 50 mL). Combined EtOAc extracts was dried over anhydrous MGS04, concentrated, and the 4- (1-imidazolyl)-benzonitrile was isolated by column chromatography (3.6 g, 78percent). LCMS: MH+ = 170 ;'H NMR (CDCI3) 8 8.0 (s, 1 H), 7.5 (d, 2H), 7.4 (m, 3H), 7.3 (d, 1H)
Reference: [1] Patent: WO2004/22561, 2004, A1, . Location in patent: Page 100
  • 6
  • [ 1194-02-1 ]
  • [ 18156-74-6 ]
  • [ 420-56-4 ]
  • [ 25372-03-6 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 4, p. 1151 - 1154
  • 7
  • [ 1194-02-1 ]
  • [ 25372-03-6 ]
Reference: [1] Patent: US2004/209878, 2004, A1,
  • 8
  • [ 288-32-4 ]
  • [ 1194-02-1 ]
  • [ 584-08-7 ]
  • [ 25372-03-6 ]
Reference: [1] Patent: US5736548, 1998, A,
  • 9
  • [ 288-13-1 ]
  • [ 1194-02-1 ]
  • [ 25699-83-6 ]
YieldReaction ConditionsOperation in experiment
87% With potassium carbonate In N,N-dimethyl-formamide at 120℃; for 7 h; 4-( 1 H-pyrazol- 1 -yl)- benzonitrile4-Fluorobenzonitrile (204.2 g), pyrazole (138.6 g, 1.22 eq) and potassium carbonate (281.5 g, 1.22 eq) in DMF (1110 ml) were heated at 120 0C for 7 hours. The suspension was cooled to 25 0C and water (2920 ml) added. The reaction was extracted with MTBE (3 x 1460 ml) and the combined extracts were washed with water (3 x 1460 ml) and saturated aqueous sodium chloride (1460 ml). The organic phase was concentrated at atmospheric pressure until the pot temperature rose to 65 0C. Heptane (1700 ml) was added over 30 minutes at 60-65 0C, and then a further 300 ml of distillate was collected. The solution was stirred at 60-65 0C for 15 minutes and then cooled to <5 0C. The slurry was filtered and washed with heptane (2 x 200 ml), and dried under vacuum to constant weight to give the title compound as a solid (245.3 g, 87percent). <n="47"/>1H NMR (400 MHz, CDCl3): 6.51 (q, IH), 7.71 (d, 2H), 7.75 (d, IH), 7.81 (d, 2H), 7.98 (d, IH).
83% With potassium carbonate In N,N-dimethyl-formamide at 115 - 120℃; for 7 - 8 h; Inert atmosphere 5f: 4-(1H-pyrazol-1-yl)benzonitrile N,N-dimethylformamide (123.25 L) was charged to the vessel and analysed for moisture content (target<0.5percent). Potassium carbonate (34.01 kg) was then charged to the vessel followed by pyrazole (16.76 kg) and 4-fluorobenzonitrile (24.65 kg). The reaction mixture was heated to 115 to 120° C. and stirred at this temperature for between seven and eight hours under a nitrogen atmosphere. The reaction was monitored by GC (target<10percent 4-fluorobenzonitrile). The reaction was then cooled to 20-25° C. and quenched with water (369.7 L). Methyl tert-butyl ether (246.5 L) was then charged and the layers allowed to separate. The aqueous layer was washed with methyl tert-butyl ether (2 x147.9 L) and the organic layers combined. The organic layer was then washed with water (2 x 172.55 L) and aqueous brine (123.25 L, 24 wt percent). The organic phase was then concentrated to approximately 100 L at 60° C. or below at atmospheric pressure. n-Heptane (209 L) was then charged and the mixture concentrated to approximately 100 L at 60° C. or below at atmospheric pressure. The reaction was cooled to 0° C. and stirred for three hours at this temperature. The slurry was then filtered washing the filter cake with n-heptane (24.65 L). The resulting solid was dried under vacuum at 40° C. to yield the title product (28.6 kg, 99.32percent purity, 83percent yield). 1H NMR (300 MHz, DMSO-d6): 6.61 (dd, J=2.4, 1.9 Hz, 1H), 7.83 (d, J=1.4 Hz 1H), 7.94 (d, J=8.7 Hz, 2H), 8.04 (d, J=9.0 Hz, 2H), 8.65 (d, J=2.4 Hz, 1H).
80% With potassium carbonate In N,N-dimethyl-formamide at 110℃; for 16 h; Step 1. 4-(lH-Pyrazol-l-yl)benzonitrile (0847) [00269] A mixture of lH-pyrazole (15 g, 220.34 mmol), 4-fluorobenzonitrile (27 g, 222.93 mmol), potassium carbonate (60.7 g, 439.19 mmol) in DMF (200 mL) was stirred for 16 h at 110 °C. After cooling to ambient temperature, the reaction mixture was poured into water (500 mL) and the resulting solids were collected by filtration and dried under vacuum, resulting in 30 g (80percent) of 4-(lH-pyrazol-l-yl)benzonitrile. MS (ESI) m/z 170 [M+H]+.
62%
Stage #1: With sodium hydroxide In N,N-dimethyl-formamide at 80℃; for 0.5 h; Inert atmosphere
Stage #2: at 110℃; for 3 h;
Into a 50-mL 3-necked round-bottom flask purged and maintained with an inert atmosphere of nitrogen, was placed 1H-pyrazole (422 mg, 6.21 mmol, 1.50 equiv), sodium hydroxide (248 mg, 6.20 mmol, 1.50 equiv), and N,N-dimethylformamide (20 mL).
The mixture was stirred and heated to 80° C. for 30 min, then to this was added 4-fluorobenzonitrile (500 mg, 4.13 mmol, 1.00 equiv).
The resulting solution was stirred for 3 h at 110° C. in an oil bath.
The resulting solution was diluted with 50 mL of H2O.
The solids were collected by filtration and dried in an oven.
The product was obtained as 0.43 g (62percent) of a white solid.
47% With caesium carbonate In N,N-dimethyl-formamide for 2 h; Reflux A 100-mE round-bottom flask was charged with4-fluorobenzonitrile (2 g, 16.51 mmol), cesium carbonate (16 g, 49.11 mmol), N,N-dimethylformamide (20 mE) and 1 H-pyrazole (2.24 g, 32.90 mmol). The resulting solution was refluxed for 2 h. The solids were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by column chromatography eluting with ethyl acetate/petroleum ether (1:10 to 1:4 v/v) to afford 4-(1H- pyrazol-i-yl)benzonitrile as a yellow oil (1.3 g, 47percent). LCMS: (ESI) mlz 170 [M+H].
47% With caesium carbonate In N,N-dimethyl-formamide for 2 h; Reflux A 100-mL round-bottom flask was charged with 4-fluorobenzonitrile (2 g, 16.51 mmol), cesium carbonate (16 g, 49.11 mmol), N,N-dimethylformamide (20 mL) and 1H-pyrazole (2.24 g, 32.90 mmol). The resulting solution was refluxed for 2 h. The solids were removed by filtration and the filtrate was concentrated under vacuum. The residue was purified by column chromatography eluting with ethyl acetate/petroleum ether (1:10 to 1:4 v/v) to afford 4-(1H-pyrazol-1-yl)benzonitrile as a yellow oil (1.3 g, 47percent). LCMS: (ESI) m/z 170 [M+H].

Reference: [1] Patent: WO2009/61271, 2009, A1, . Location in patent: Page/Page column 45-46
[2] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 11, p. 2955 - 2959
[3] Patent: US2011/224229, 2011, A1, . Location in patent: Page/Page column 19
[4] Patent: WO2017/87837, 2017, A1, . Location in patent: Paragraph 00269
[5] Patent: US9301951, 2016, B2, . Location in patent: Page/Page column 231
[6] Patent: US2016/185785, 2016, A1, . Location in patent: Paragraph 2106; 2107
[7] Patent: US2016/185786, 2016, A1, . Location in patent: Paragraph 0629
  • 10
  • [ 1194-02-1 ]
  • [ 25699-83-6 ]
Reference: [1] Patent: US6498172, 2002, B1,
  • 11
  • [ 110-85-0 ]
  • [ 1194-02-1 ]
  • [ 68104-63-2 ]
YieldReaction ConditionsOperation in experiment
95% With potassium carbonate In butanone for 96 h; Reflux A mixture of 4-fluorobenzonitrile (3, 0.36 g, 3 mmol), piperazine (0.64 g, 7.4 mmol) and K2CO3 (0.85 g, 6.1 mmol) in ethylmethylketone (50 mL) was refluxed for 4 days. The completion of reaction was detected by TLC. The solvent was evaporated under reduced pressure and then chloroform and water was added. The organic layer was extracted. After evaporation of chloroform, the residue was crystallized from chloroform to give compound 4 as a cream solid. Yield: 95percent; m.p 82-85 °C; IR (KBr, cm-1): 3325, 2215, 1606. 1H NMR (500 MHz, CDCl3): 7.50 (d, 2H, J = 9.2 Hz, phenyl), 6.86 (d, 2H, J = 9.2 Hz, phenyl), 3.29 (t, 4H, J = 5.2 Hz, piperazine), 3.02 (t, 4H, J = 5.2 Hz, piperazine). MS (ESI): 188 [M + H+]. Anal. Calcd for C11H13N3: C, 70.56; H, 7.0; N, 22.44. Found: C, 70.35; H, 6.82; N, 22.73.
93.6% With potassium carbonate In dimethyl sulfoxide a)
Potassium carbonate (20.7 g, 0.15 mol) was added to a solution of 4-fluorobenzonitrile (12.1 g, 0.1 mol) and piperazine (25.8 g, 0.3 mol) in dimethylsulfoxide (75 ml) and heated at 95° C. for 20 hours.
The reaction was cooled and poured into water (1100 ml) and extracted into dichloromethane (4*400 ml).
The organic solution was dried and the solvent removed in vacuo to yield 4-cyanophenylpiperazine (17.5 g, 93.6percent yield):
1H-NMR (CDCl3): 7.50 (d, 2H), 6.80 (d, 2H), 3.25 (m, 4H), 3.00 (m, 4H);
MS (+ve ESI): 188 (M+H)+.
Reference: [1] Journal of Medicinal Chemistry, 1994, vol. 37, # 23, p. 3882 - 3885
[2] European Journal of Medicinal Chemistry, 2011, vol. 46, # 6, p. 2602 - 2608
[3] Patent: US7235559, 2007, B1,
[4] Phosphorus, Sulfur and Silicon and the Related Elements, 2008, vol. 183, # 5, p. 1252 - 1263
  • 12
  • [ 110-85-0 ]
  • [ 1194-02-1 ]
  • [ 101722-12-7 ]
  • [ 68104-63-2 ]
Reference: [1] Organic Process Research and Development, 2018,
[2] Organic Process Research and Development, 2018,
[3] Organic Process Research and Development, 2018, vol. 22, # 9, p. 1086 - 1091
  • 13
  • [ 1194-02-1 ]
  • [ 68104-63-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2011, vol. 54, # 8, p. 3086 - 3090
  • 14
  • [ 109-01-3 ]
  • [ 1194-02-1 ]
  • [ 34334-28-6 ]
YieldReaction ConditionsOperation in experiment
93% With potassium carbonate In dimethyl sulfoxide To a mixture of 4-FLUORO- benzonitrile 42B (1.0 g, 8. 25 MMOL) and K2CO3 (2.27 mg, 16.51 MMOL) in dimethyl sulfoxide (7 mL) was added 1-methyl piperazine (1.36 mL, 12. 38 MMOL) and the reaction continued as described above to afford amine 1.54 g of 45b in 93percent YIELDS. 1H-NMR (500 MHz, CDC . S) : No. 2.36 (3Hs, s), 2.55 (4Hs, t, J = 4. 88 Hz), 3.35 (4Hs, t, J = 4. 88 Hz), 6. 87 (2Hs, d, J = 8. 78 Hz), 7.49 (2Hs, d, J = 8. 78 Hz); ESI-MASS : 202. 1 (M+1).
84% With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 18 h; To a solution of 4-fluorobenzonitrile (0.041 mol, 5 g) in DMF (10 ml) were added K2C03 (0.082 mol, 11.4 g) and 1 -methylpiperazine (0.062 mol, 6.15 g). The mixture was stirred over 1 8h at 100°C. The mixture was partitioned between water and ethyl acetate. The organic phase was washed with water and brine. The resulting solution was dried oversodium sulfate and evaporated to dryness. The title compound was obtained as a white solid and used without further purification (7 g, 84percent).(ESI+) MS: m/z 202.3 (MHj.
77% at 90℃; for 15 h; 4-(4-Methylpiperazin-1-yl)benzamide
4-Fluorobenzonitrile (12 g, 99 mmol, 1 eq.) and 100 mL of DMF are placed in a 250 mL round-bottomed flask. N-Methylpiperazine (16 mL, 1.6 eq., 123 mmol) is added to this solution.
The orange solution is heated at a temperature in the region of 90° C. for 15 hours.
The solvent is then evaporated to dryness and the residue is diluted with 500 mL of diethyl ether.
The solution is washed with sodium hydrogen carbonate solution (2*100 mL) and then with saturated sodium chloride solution (100 mL).
After evaporation, the 4-(4-methylpiperazin-1-yl)benzonitrile (orange solid, 10 g, 77percent) is used without further purification in the following hydrolysis step.
It is added at a temperature in the region of 0° C. to a solution of 98percent sulfuric acid (25 mL) and 5 mL of water.
The purple solution is then heated at a temperature in the region of 100° C. for 8 hours.
The solution is cooled and then hydrolyzed by pouring onto ice.
The pH is adjusted to 9-10 with sodium hydroxide pellets.
The precipitate obtained is filtered off and washed thoroughly with water and then with tetrahydrofuran, which partially dissolves the product.
The water is separated out by settling.
After evaporating the organic phase to dryness, a solid is obtained, which is purified by chromatography on silica gel, eluding with a methanol/dichloromethane mixture (15/85 by volume).
4-(4-Methylpiperazin-1-yl)benzamide (8.7 g, 80percent) is thus obtained in the form of a white solid, which is used directly in the following step.
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 26, p. 8261 - 8269
[2] Patent: WO2005/7625, 2005, A2, . Location in patent: Page 63
[3] Phosphorus, Sulfur and Silicon and the Related Elements, 2008, vol. 183, # 5, p. 1252 - 1263
[4] Patent: WO2016/96709, 2016, A1, . Location in patent: Page/Page column 50
[5] Patent: US2008/146542, 2008, A1, . Location in patent: Page/Page column 36
[6] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 5, p. 1529 - 1534
[7] Patent: EP1577288, 2005, A1, . Location in patent: Page/Page column 96-97
[8] Patent: US2002/193389, 2002, A1,
[9] Patent: US6127541, 2000, A,
[10] Patent: US2005/222408, 2005, A1,
[11] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5293 - 5305
[12] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 7, p. 741 - 745
  • 15
  • [ 186650-77-1 ]
  • [ 1194-02-1 ]
  • [ 53617-35-9 ]
Reference: [1] Patent: US6288061, 2001, B1,
  • 16
  • [ 110-91-8 ]
  • [ 1194-02-1 ]
  • [ 7470-38-4 ]
YieldReaction ConditionsOperation in experiment
99% With hydrogenchloride; sodium hydroxide In water Example 10
Preparation of 4-(4-morpholinyl) Benzoic Acid Staring From 4-fluorobenzonitrile by the One-Pot Method Using Basic Hydrolysis:
A mixture of 4-fluorobenzonitrile (5.04 g, 41.6 mmol) and morpholine (9.12 g, 104.6 mmol) is heated at 120° C. to achieve a complete conversion of 4-fluorobenzonitrile after 5 hours.
Water (100 ml) and NaOH (4.1 g, 10 mmol) are added to the reaction mixture.
The whole mixture is kept refluxing for another 5 h, cooled down to room temperature and made acidic by the addition of HCl (5percent) with efficient stirring.
The precipitate is filtered off, washed with water and dried under vacuum (60° C.) to give 8.34 g of the title-compound. Yield: 99percent; m.p. 275-277° C.; MS 207 (100, M+); H1 NMR (DMSO): 12.33 (b, 1H), 7.78 (d, 2H), 6.95 (d, 2H), 3.72 (t, 2H), 3.23 (t, 2H); δ C3 NMR (CDCl3): δ 167.25, 153.90, 130.81, 119.91, 113.22, 65.87, 46.97.
Reference: [1] Patent: US2003/171581, 2003, A1,
  • 17
  • [ 110-91-8 ]
  • [ 934012-95-0 ]
  • [ 1194-02-1 ]
  • [ 7470-38-4 ]
Reference: [1] Patent: US2003/171581, 2003, A1,
  • 18
  • [ 1194-02-1 ]
  • [ 7470-38-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 5, p. 1529 - 1534
  • 19
  • [ 74-96-4 ]
  • [ 1194-02-1 ]
  • [ 456-03-1 ]
Reference: [1] European Journal of Pharmaceutical Sciences, 2011, vol. 43, # 5, p. 386 - 392
  • 20
  • [ 15097-49-1 ]
  • [ 1194-02-1 ]
  • [ 10282-30-1 ]
YieldReaction ConditionsOperation in experiment
71%
Stage #1: With cesium fluoride In N,N-dimethyl-formamide for 0.166667 h; Inert atmosphere
Stage #2: at 20℃; for 144 h;
Under a nitrogen atmosphere, 320 mg (2.11 mmol) of CsF were suspended in 5 ml of DMF and stirred for 30 min. Then, 1.00 g (8.26 mmol) of 4-fluorobenzonitrile were added. After 10 min 1.44 ml (8.25 mmol) of N-trimethylsilylpyrrolidine were added, and the mixture was stirred for 6 d at room temperature. For workup, 5 ml of water and 5 ml of CH2Cl2 were added to the reaction mixture. The organic phase was separated, the aqueous phase was extracted with CH2Cl2, the organic phases were combined, washed several times with water and dried over MgSO4, and the solvent was removed under vacuum.Yield: 1.01 g (5.87 mmol, 71percent), appearance: pale yellow solid. 1H NMR (CDCl3, 25° C., 400.13 MHz): δ=2.00-2.07 (m, 4H, H-8, H-9), 3.30-3.34 (m, 4H, H-7, H-10), 6.47-6.51 (m, 2H, H-3, H-5), 7.42-7.46 (m, 2H, H-2, H-6). 13C NMR (CDCl3, 25° C., 100.61 MHz): δ=25.5 (C-8, C-9), 47.6 (C-7, C-10), 96.7 (C-1), 111.6 (C-3, C-5), 121.1 (-CN), 133.6 (C-2, C-6), 150.1 (C-4).
Reference: [1] Patent: US2012/142937, 2012, A1, . Location in patent: Page/Page column 5
  • 21
  • [ 123-75-1 ]
  • [ 1194-02-1 ]
  • [ 10282-30-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
[2] European Journal of Medicinal Chemistry, 2010, vol. 45, # 9, p. 3709 - 3718
[3] Patent: US2002/193389, 2002, A1,
[4] Patent: US6127541, 2000, A,
  • 22
  • [ 15097-49-1 ]
  • [ 1194-02-1 ]
  • [ 10282-30-1 ]
  • [ 420-56-4 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 4, p. 1151 - 1154
  • 23
  • [ 1194-02-1 ]
  • [ 36282-26-5 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 9, p. 2473 - 2477[2] Angew. Chem., 2017, vol. 129, p. 2513 - 2517,5
  • 24
  • [ 75-63-8 ]
  • [ 1194-02-1 ]
  • [ 67515-59-7 ]
Reference: [1] Angewandte Chemie - International Edition, 2016, vol. 55, # 8, p. 2782 - 2786[2] Angew. Chem., 2016, vol. 128, # 8, p. 2832 - 2836,5
  • 25
  • [ 1194-02-1 ]
  • [ 76-05-1 ]
  • [ 67515-59-7 ]
  • [ 194853-86-6 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 1, p. 38 - 41
  • 26
  • [ 1194-02-1 ]
  • [ 1605-18-1 ]
  • [ 350-40-3 ]
Reference: [1] Tetrahedron Letters, 2003, vol. 44, # 9, p. 1907 - 1910
  • 27
  • [ 1194-02-1 ]
  • [ 350-40-3 ]
Reference: [1] Synthesis, 2003, # 11, p. 1643 - 1648
  • 28
  • [ 1194-02-1 ]
  • [ 1009-35-4 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 19, p. 8088 - 8094
[2] Journal of the American Chemical Society, 1961, vol. 83, p. 4564 - 4571
[3] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1972, p. 906 - 911
[4] Patent: US5360809, 1994, A,
[5] Patent: EP563001, 1993, A1,
  • 29
  • [ 1194-02-1 ]
  • [ 4640-67-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1979, vol. 22, # 11, p. 1385 - 1389
  • 30
  • [ 1194-02-1 ]
  • [ 1999-00-4 ]
YieldReaction ConditionsOperation in experiment
93%
Stage #1: at 0 - 25℃; for 26 h;
Stage #2: With hydrogenchloride In tetrahydrofuran; water at 20 - 25℃; for 1 h;
Under nitrogen atmosphere, 30 ML of THF was added to 6.09 g (10 mmol, 1.0 equivalent) of (BrZnCH2COOEt*THF)2..
Under argon atmosphere, a solution of 1.21 g (10 mmol) of 4-fluorobenzonitrile in 5 ML of THF was added dropwise while stirring at 0.similar.5°C.
The mixture was stirred at 20.similar.25°C for 26 hours. 15 ML of 10percent hydrochloric acid was added dropwise at 20°C or lower, and the mixture was stirred at 20.similar.25°C for 1 hour, followed by dilution with ethyl acetate..
Then, the layers were separated..
The organic layer was washed successively with 15 ML of 1N hydrochloric acid, 20 ML of an aqueous saturated sodium chloride solution, 20 ML (*2) of an aqueous saturated sodium bicarbonate solution, and 20 ML of an aqueous saturated sodium chloride solution..
After washing, the organic layer was dried with anhydrous magnesium sulfate..
Concentration under reduced pressure afforded 1.96 g of the desired product (yield 93percent).1H NMR (CDCl3), (ppm): δ [1.26 (t, J=7.1 Hz), 1.34 (t,J=7.1 Hz)] (3H), [3.96 (s), 5.61 (s), 12.6 (s)] (2H), 4.18-4.25 (2H, m), 7.07-8.02 (4H, m).
Reference: [1] Patent: EP1471056, 2004, A1, . Location in patent: Page 45
  • 31
  • [ 1194-02-1 ]
  • [ 59142-68-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2017, vol. 56, # 9, p. 2473 - 2477[2] Angew. Chem., 2017, vol. 129, p. 2513 - 2517,5
  • 32
  • [ 1194-02-1 ]
  • [ 13205-47-5 ]
  • [ 99985-67-8 ]
Reference: [1] Patent: US5378728, 1995, A,
  • 33
  • [ 1194-02-1 ]
  • [ 75-65-0 ]
  • [ 13205-47-5 ]
Reference: [1] Chemical Biology and Drug Design, 2016, vol. 87, # 3, p. 382 - 397
  • 34
  • [ 1194-02-1 ]
  • [ 107622-80-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2001, vol. 44, # 14, p. 2344 - 2356
  • 35
  • [ 1194-02-1 ]
  • [ 94341-56-7 ]
Reference: [1] Patent: WO2012/31199, 2012, A1,
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 17, p. 4875 - 4885
[3] Patent: WO2013/127268, 2013, A1,
  • 36
  • [ 1194-02-1 ]
  • [ 873-55-2 ]
  • [ 94341-56-7 ]
Reference: [1] Patent: WO2012/31197, 2012, A1,
  • 37
  • [ 1194-02-1 ]
  • [ 456-14-4 ]
YieldReaction ConditionsOperation in experiment
35.5% With ammonia In diethyl ether; ethanol EXAMPLE 40
4-Fluorobenzamidine Hydrochloride
4-Fluorobenzonitrile (10 g, 83 mmol) is dissolved in a mixture of anhydrous ethanol (5 mL) and diethyl ether (70 mL).
The reaction mixture is cooled to ice-bath temperature and saturated with gaseous hydrogen chloride for 90 minutes.
The mixture is allowed to warm to ambient temperature and stirred overnight.
The colorless precipitates are filtered off, washed with diethyl ether and dissolved in anhydrous ethanol (20 mL).
Diethyl ether (100 mL) saturated with gaseous ammonia is added and the solution is stirred for 3 hours.
The resulting suspension is filtered and the solvent of the filtrate is removed in vacuo.
The residue is washed with diisopropyl ether.
After drying colourless crystals (5.15 g, 35.5percent) of melting point 210° C. are obtained.
Reference: [1] Magnetic Resonance in Chemistry, 1987, vol. 25, p. 923 - 927
[2] Patent: US5849758, 1998, A,
[3] Journal of Medicinal Chemistry, 1990, vol. 33, # 4, p. 1230 - 1241
[4] Patent: US2003/139415, 2003, A1,
[5] Tetrahedron, 2014, vol. 70, # 8, p. 1635 - 1645
  • 38
  • [ 92292-00-7 ]
  • [ 1194-02-1 ]
  • [ 38646-68-3 ]
Reference: [1] Patent: US6288061, 2001, B1,
  • 39
  • [ 1194-02-1 ]
  • [ 100-83-4 ]
  • [ 90178-72-6 ]
Reference: [1] Liebigs Annalen der Chemie, 1984, vol. 1984, # 3, p. 409 - 425
[2] Patent: WO2006/123725, 2006, A1, . Location in patent: Page/Page column 46
  • 40
  • [ 1194-02-1 ]
  • [ 99662-34-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2006, vol. 16, # 11, p. 2955 - 2959
  • 41
  • [ 1194-02-1 ]
  • [ 146137-79-3 ]
YieldReaction ConditionsOperation in experiment
79% With n-butyllithium; acetic acid; diisopropylamine In tetrahydrofuran; <i>N</i>-methyl-acetamide; hexane; water EXAMPLE 112
2-Fluoro-5-cyano-benzaldehyde
To a stirred, cooled solution (0° C.) of diisopropylamine (15.4 mL, 0.11 mol) in anhydrous tetrahydrofuran (200 mL) n-butyllithium (40 mL of 2.5M in hexane, 0.11 mol) was added from a dropping funnel over a period of 30 min. under argon.
The mixture was stirred at that temperature for 30 min. and then cooled to -78° C. A solution of 4-fluoro-benzonitrile (12.1g, 0.1 mol) in dry THF (50 mL) was then added dropwise over 15 min. via syringe and stirred for 1 hour at -78° C. Dimethylformamide (8 mL) was added dropwise from a syringe and the stirring was continued for another 20 min.
The reaction was quenched by the rapid addition of acetic acid (20 mL) followed by water (500 mL) and the product was extracted with diethyl ether (2*500 mL).
The combined organic layers were washed with 1N HCl, water, saturated sodium chloride and then dried over anhydrous magnesium sulfate, and evaporated to give 2-fluoro-5-cyano-benzaldehyde (11.8 g, 79percent yield) as a light yellow solid.
1H NMR (CDCl3): δ10.32 (s, 1H), 8.18 (dd, 1H, J=6.5, 2.5 Hz), 7.88 (m, 1H), 7.33 (t, 1H, J=9.5 Hz).
74.6% With acetic acid; diisopropylamine In <i>N</i>-methyl-acetamide; ethyl acetate A.
4-Fluoro-3-Formylbenzenecarbonitrile
Lithium diisopropyi amide (LDA) (22 mL, 49.56 mmol, 2.0 N commercial solution in heptanes) was added to tetrahydrofliran (50 mL), cooled to 78° C. and under nitrogen.
4-Fluorobenzonitrile was weighed out (5.0 g, 41.3 imnol), placed under nitrogen and dissolved in 25 mL of dry tetrahydrofliran.
This solution was added dropwise to the solution of LDA.
The resulting solution was stirred at -78° C. for one hour before quenching with 4 mL of dimethylformamide.
The temperature was maintained for 10 min before adding 8 mL of acetic acid and 20 mL of distilled water.
The crude product was extracted with ethyl acetate.
Purification by column chromatography (SiO2, 20percent ethyl acetate in hexanes) afforded 4.6 g of pure product as a white solid (74.6percent yield).
-A second batch of the title compound (3.5 g, 56.8 percent/yield) was prepared 20 using 5 g of benzonitrile (41.3 mmol): 1H NMR (CDCl3) δ 10.3 (s, 1H), 8.21 (dd, 1H), 7.91 (d of q, 1H), 7.35 (t, 1H); ES-MS M+was not detected.
Reference: [1] Patent: US6221914, 2001, B1,
[2] Patent: US2002/103229, 2002, A1,
[3] Patent: US2004/127536, 2004, A1,
[4] Patent: US2005/9876, 2005, A1,
  • 42
  • [ 1194-02-1 ]
  • [ 68-12-2 ]
  • [ 146137-79-3 ]
Reference: [1] Tetrahedron Letters, 1992, vol. 33, # 49, p. 7499 - 7502
[2] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 3, p. 561 - 566
  • 43
  • [ 124-38-9 ]
  • [ 1194-02-1 ]
  • [ 146328-87-2 ]
Reference: [1] Tetrahedron Letters, 1992, vol. 33, # 49, p. 7495 - 7498
  • 44
  • [ 1194-02-1 ]
  • [ 76-05-1 ]
  • [ 67515-59-7 ]
  • [ 194853-86-6 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 1, p. 38 - 41
  • 45
  • [ 1194-02-1 ]
  • [ 333954-86-2 ]
YieldReaction ConditionsOperation in experiment
91%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 1 h;
Stage #2: at 60℃; for 0.5 h;
Step A: tert-Butyl-4-(4-cvanophenyloxy)- 1 -piperidinecarboxylate <n="102"/>To tert-butyl 4-hydroxy- 1 -piperidinecarboxylate (24.1 g, 100. 0 mmol) in dimethylformamide (250 mL) is added sodium hydride (60percent emulsion in mineral oil) (8.00 g, 200.0 mmol) and the mixture is stirred at rt for 1 h. 4-Fluorobenzonitrile (12.1 g, 100.0 mmol) is added, the mixture is heated to 60 0C for 30 minutes, diluted with ethyl acetate and the reaction is quenched by the addition of water. The organic phase is evaporated in vacuo and purified on silica gel to give the desired product (27.5 g, 91percent).
Reference: [1] Patent: WO2007/106705, 2007, A1, . Location in patent: Page/Page column 100-101
  • 46
  • [ 1194-02-1 ]
  • [ 109384-19-2 ]
  • [ 333954-86-2 ]
YieldReaction ConditionsOperation in experiment
52%
Stage #1: With sodium hydride In DMF (N,N-dimethyl-formamide) at 50℃; for 0.75 h;
Stage #2: at 50℃; for 2 h;
Example 9 4- (1-Benzyl-piperidin-4-yloxy)-benzamide Step 1 4- (4-Cyano-phenoxy)-piperidine-1-carboxylic acid tert-butyl ester Add a solution of N-Boc-4-hydroxypiperidine (3.0 g, 14.9 mmol) in DMF (5 mL) to a suspension of sodium hydride (894 mg, 22.4 mmol) in DMF (17 mL). Stir the reaction mixture while heating at 50°C for 45 min. Then add a solution of 4-fluoro- benzonitrile (2.16 g, 17.9 mmol) in DMF (5 mL). Stir and heat at 50°C for 2h. Let cool to room temperature and quench with water (0.5 mL). Evaporate DMF. Redissolved the resulting residue in EtOAc/hexanes (2/1,20 mL) and wash with water (3x15 mL). Dry the organic layer over magnesium sulfate, filter and concentrate. Purify by chromatography (EtOAc/hexanes 20percent and EtOAc/hexanes 10percent) to yield the title compound (2.32 g, 52percent).
Reference: [1] Patent: WO2005/61442, 2005, A1, . Location in patent: Page/Page column 44
[2] Patent: WO2004/37800, 2004, A1, . Location in patent: Page 26
[3] Patent: WO2004/37788, 2004, A1, . Location in patent: Page 17
  • 47
  • [ 1194-02-1 ]
  • [ 333954-86-2 ]
Reference: [1] Patent: WO2015/69110, 2015, A1, . Location in patent: Page/Page column 54; 55
  • 48
  • [ 1194-02-1 ]
  • [ 216144-45-5 ]
Reference: [1] Journal of Medicinal Chemistry, 2005, vol. 48, # 26, p. 8261 - 8269
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 12, p. 5293 - 5305
[3] ACS Medicinal Chemistry Letters, 2018, vol. 9, # 7, p. 741 - 745
  • 49
  • [ 1194-02-1 ]
  • [ 114365-04-7 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3651 - 3660
  • 50
  • [ 121-43-7 ]
  • [ 1194-02-1 ]
  • [ 468718-30-1 ]
  • [ 468717-46-6 ]
YieldReaction ConditionsOperation in experiment
70% With hydrogenchloride; n-butyllithium; diisopropylamine In tetrahydrofuran EXAMPLE 163
3-(2-Dimethylaminomethyl-cyclopropyl)-1H-indazole-5-carbonitrile
n-BuLi (1.9 M, 26.3 mL, 50 mmol) was added dropwise to a solution of diisopropylamine (7.71 mL, 55 mmol) in 100 mL anhydrous THF under N2 at 0° C.
After 10 minutes, the reaction was cooled to -78° C. A solution of 4-fluorobenzonitrile (6.06 g, 50 mmol) in 20 mL anhydrous THF was added dropwise, at such a rate to maintain an internal temperature of -78° C.
After stirring for 1 h at this temperature, trimethyl borate (8.41 mL, 75 mmol) was added dropwise at such a rate to maintain an internal temperature of -78° C.
The reaction was stirred and gradually warmed to room temperature over 16 h.
The reaction was cooled to 10° C. and 25 mL 6N HCl was added.
After stirring at room temperature for 4 h, the reaction was partitioned between water and ethyl acetate.
The organic layer was washed three times with 100 mL 2N NaOH.
The aqueous layers were pooled and adjusted to pH 6 with 6N HCl.
The white solid which forms was extracted by three washes of 100 mL Ethyl acetate.
The organic layers were pooled, dried over sodium sulfate, concentrated and dried under high vacuum to give 2-fluoro-5-cyanophenyl boronic acid (5.74 g, 70percent).
1H NMR (500 MHz, acetone-d6) 8.08 (1 H, dd, J=2.14, 5.5 Hz), 7.90 (1 H, m), 7.31 (1 H, t, J=8.85 Hz). Anal. calcd. for C7H5BFNO2: C, 50.97; H, 3.05; N, 8.49. Found: C, 51.19; H, 3.19; N, 8.26.
Reference: [1] Patent: US2003/73849, 2003, A1,
  • 51
  • [ 1194-02-1 ]
  • [ 252017-04-2 ]
Reference: [1] Organic Process Research and Development, 2012, vol. 16, # 3, p. 447 - 460
  • 52
  • [ 1194-02-1 ]
  • [ 368870-03-5 ]
Reference: [1] Patent: US9301951, 2016, B2,
[2] Patent: WO2017/87837, 2017, A1,
  • 53
  • [ 1194-02-1 ]
  • [ 906673-45-8 ]
Reference: [1] Patent: WO2018/115362, 2018, A1,
  • 54
  • [ 1194-02-1 ]
  • [ 2973-80-0 ]
  • [ 906673-54-9 ]
YieldReaction ConditionsOperation in experiment
71% With potassium carbonate In N,N-dimethyl-formamide; toluene at 115℃; for 8 h; Inert atmosphere In a round bottom flask, under nitrogen atmosphere, 2-bromo-5-hydroxybenzaldehyde (100 g, 497 mmol) and 4-fluorobenzonitrile (301 .2 g, 2487 mmol) were dissolved in DMF (250 ml) and toluene (500 ml). To the resulting dark solution, potassium carbonate (206.2 g, 1492 mmol) was added and the resulting mixture was stirred for 8 hours at 1 15 °C. After the reaction was completed by TLC, the heterogeneous mixture was filtered. The solvents and 4-fluoro-benzonitrile were distilled under reduced pressure from the obtained filtrate. Ethyl acetate (800 ml), water (500 ml) and brine (40 ml) were added and the formed phases were separated at 65-70 °C. The aqueous phase was extracted with ethyl acetate (150 ml) at 65-70 °C and the combined organic phase was washed with a mixture of water (225 ml) and brine (180 ml) at 65-70 °C. The obtained organic phase was evaporated under reduced pressure to give a brown solid. The solid was purified twice by recrystallization in a hot mixture of ethyl acetate and toluene to give 4-(4-bromo-3- formylphenoxy)benzonitrile (compound A) (107.5 g). Yield: 71 percent Purity by HPLC: >99percent 1H-NMR (200 MHz, CDCI3, δ ppm): 10.32 (1 H, s); 7.62-7.72 (3H, m); 7.57-7.59 (1 H, dd; J= 3, J= 1 ); 7.18- 7.23 (1 H, dd, J=8 Hz, J=3 Hz), 7.01 -7.08 (2H, m) 13C-NMR (50 MHz, CDCI3, δ ppm): 190.69; 160.08; 155.13; 135.59; 134.89; 134.39; 126.86; 121.81 ; 120.28; 1 18.68; 1 18.33; 107.32 DSC: Endothermic peak at 1 1 1.9 °C.
50 g With potassium carbonate In N,N-dimethyl-formamide at 75 - 85℃; for 20 h; A mixture of 2-bromo-5-hydroxybenzaldehyde (50g), 4-fluorobenzonitrile (75.3 lg) and potassium carbonate (103g) in dimethylformamide (500mL) was stirred at about 75°C to about 85°C for about 20h. The reaction mixture was filtered and the filtrate was quenched with water at about room temperature, stirred for about 2h, filtered and dried. The crude product was purified by ethyl acetate. Yield: 50g HPLC purity: >99percent
Reference: [1] Patent: WO2018/115362, 2018, A1, . Location in patent: Paragraph 0120
[2] Patent: US2007/72833, 2007, A1, . Location in patent: Page/Page column 20
[3] Patent: WO2018/224923, 2018, A1, . Location in patent: Paragraph 0167; 0181
  • 55
  • [ 1160182-44-4 ]
  • [ 1194-02-1 ]
  • [ 1217366-74-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 8, p. 2129 - 2132
  • 56
  • [ 1194-02-1 ]
  • [ 132089-35-1 ]
Reference: [1] European Journal of Inorganic Chemistry, 2015, vol. 2015, # 29, p. 4935 - 4945
[2] Medicinal Chemistry Research, 2016, vol. 25, # 10, p. 2399 - 2409
Same Skeleton Products
Historical Records

Similar Product of
[ 1194-02-1 ]

Chemical Structure| 1026413-78-4

A1537532[ 1026413-78-4 ]

4-Fluorobenzonitrile-cyano-13C

Reason: Stable Isotope

Chemical Structure|

A1537392[ ]

4-Fluorobenzonitrile-benz-13C6

Reason: Stable Isotope

Related Functional Groups of
[ 1194-02-1 ]

Fluorinated Building Blocks

Chemical Structure| 453565-55-4

[ 453565-55-4 ]

5-Fluoroisophthalonitrile

Similarity: 0.97

Chemical Structure| 185147-08-4

[ 185147-08-4 ]

4-Fluoro-3-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 216976-30-6

[ 216976-30-6 ]

3-Fluoro-5-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 85070-67-3

[ 85070-67-3 ]

2-Fluoro-4-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 147754-12-9

[ 147754-12-9 ]

4-Fluoro-2-methylbenzonitrile

Similarity: 0.94

Aryls

Chemical Structure| 453565-55-4

[ 453565-55-4 ]

5-Fluoroisophthalonitrile

Similarity: 0.97

Chemical Structure| 185147-08-4

[ 185147-08-4 ]

4-Fluoro-3-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 216976-30-6

[ 216976-30-6 ]

3-Fluoro-5-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 85070-67-3

[ 85070-67-3 ]

2-Fluoro-4-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 147754-12-9

[ 147754-12-9 ]

4-Fluoro-2-methylbenzonitrile

Similarity: 0.94

Nitriles

Chemical Structure| 453565-55-4

[ 453565-55-4 ]

5-Fluoroisophthalonitrile

Similarity: 0.97

Chemical Structure| 185147-08-4

[ 185147-08-4 ]

4-Fluoro-3-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 216976-30-6

[ 216976-30-6 ]

3-Fluoro-5-methylbenzonitrile

Similarity: 0.97

Chemical Structure| 85070-67-3

[ 85070-67-3 ]

2-Fluoro-4-methylbenzonitrile

Similarity: 0.94

Chemical Structure| 147754-12-9

[ 147754-12-9 ]

4-Fluoro-2-methylbenzonitrile

Similarity: 0.94